iPrime Canaloplasty and iStent Infinite

Show Description +

Billy Pan, MD, presents the case of a patient who had cataract surgery with iStent placement back in 2015. Given uncontrolled IOP despite maximum medical therapy, we decided to pursue a combination of an iPrime Canaloplasty (Glaukos) and the additional placement of iStents via the newly FDA approved Infinite system (Glaukos).

Posted: 3/29/2023

Keywords:

iStent

iPrime Canaloplasty and iStent Infinite

Billy Pan, MD, presents the case of a patient who had cataract surgery with iStent placement back in 2015. Given uncontrolled IOP despite maximum medical therapy, we decided to pursue a combination of an iPrime Canaloplasty (Glaukos) and the additional placement of iStents via the newly FDA approved Infinite system (Glaukos).

Posted: 3/29/2023

Keywords:

iStent

Please log in to leave a comment.

More in Glaucoma

Evaluating Safety of MIGS and Interventional Glaucoma

Kevin Gillmann, MD, MBBS, FEBOphth, MArch, PgCert (HMS)

Advancing MIGS Safety and Predictability With iStent infinite®

Imran Masood, BSc, MB ChB, MRCS(Ed), FRCOphth

Trabeculectomy Pearls From the Moran Eye Center

Rachel G. Simpson, MD; and Roya Garakani, DO